SCHEMBL9404401

SCHEMBL9404401

CO/N=C/C1=C(Cl)CCN(C)C1

nearest known ligand 0.46

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.46
CHRM5 P08912 1/20 0.46
CHRM1 P11229 1/20 0.46
MAOA P21397 2/20 0.32
MAOB P27338 2/20 0.32
SLC6A4 P31645 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9404436 0.79 MAOA (0.31) MAOAMAOB
SCHEMBL9498998 0.63 CHRM2 (0.56) CHRM2CHRM5CHRM1
SCHEMBL12043297 0.63 CHRM2 (0.56) CHRM2CHRM5CHRM1
Milameline SCHEMBL8730187 0.62 CHRM2 (0.97) CHRM2CHRM5CHRM1
Milameline SCHEMBL5819625 0.62 CHRM2 (0.97) CHRM2CHRM5CHRM1
SCHEMBL12867629 0.62 ADRA2A (0.33) MAOAMAOB
SCHEMBL19243978 0.61 ALDH1A1 (0.34) MAOAMAOBSLC6A4
SCHEMBL21323127 0.59 MEN1 (0.37) CHRM2CHRM5MAOAMAOB
SCHEMBL18600363 0.59
SCHEMBL6453856 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0316718-B1 AZACYCLIC COMPOUNDS AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1993-09-15 EP claimed
US-5356912-A 3-(5-isoxazolyl)-1-methyl-1,2,3,6-tetrahydropyridine useful for treating Alzheimer's disease NOVO NORDISK A/S (DK) 1994-10-18 US disclosed
US-5262427-A Cognition activators for Alzheimer*s disease NOVO NORDISK A/S (DK) 1993-11-16 US disclosed
EP-0316718-B1 AZACYCLIC COMPOUNDS AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1993-09-15 EP disclosed